Barro, Christian

Neurofilaments as biomarkers in neurological disorders

Khalil, M., Teunissen, C. E., Otto, M., Piehl, F., Sormani, M. P., Gattringer, T., Barro, C., Kappos, L., Comabella, M., Fazekas, F., et al. (2018) · Nature Reviews Neurology

Multiple Sclerosis Research StudiesHereditary Neurological Disorders

Cited by 1,988

Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis

Disanto, G., Barro, C., Benkert, P., Naegelin, Y., Schädelin, S., Giardiello, A., Zecca, C., Blennow, K., Zetterberg, H., Leppert, D., et al. (2017) · Annals of Neurology

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 1,164

Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease

Dominantly Inherited Alzheimer Network, Preische, O., Schultz, S. A., Apel, A., Kuhle, J., Kaeser, S. A., Barro, C., Gräber, S., Kuder-Buletta, E., LaFougere, C., et al. (2019) · Nature Medicine

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 927

Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa

Kuhle, J., Barro, C., Andreasson, U., Derfuss, T., Lindberg, R., Sandelius, Å., Liman, V., Norgren, N., Blennow, K., & Zetterberg, H. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM)

Multiple Sclerosis Research StudiesAdvanced Biosensing Techniques and Applications

Cited by 740

Serum neurofilament light levels in normal aging and their association with morphologic brain changes

Khalil, M., Pirpamer, L., Hofer, E., Voortman, M. M., Barro, C., Leppert, D., Benkert, P., Ropele, S., Enzinger, C., Fazekas, F., et al. (2020) · Nature Communications

Dementia and Cognitive Impairment ResearchCerebrovascular and genetic disorders

Cited by 572

Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis

Barro, C., Benkert, P., Disanto, G., Tsagkas, C., Amann, M., Naegelin, Y., Leppert, D., Gobbi, C., Granziera, C., Yaldizli, Ö., et al. (2018) · Brain

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 517

Blood neurofilament light: a critical review of its application to neurologic disease

Barro, C., Chitnis, T., & Weiner, H. L. (2020) · Annals of Clinical and Translational Neurology

Multiple Sclerosis Research StudiesHereditary Neurological Disorders

Cited by 296

Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis

Meier, S., Willemse, E. A. J., Schaedelin, S., Oechtering, J., Lorscheider, J., Melie-Garcia, L., Cagol, A., Barakovic, M., Galbusera, R., Subramaniam, S., et al. (2023) · JAMA Neurology

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 289

Neurofilament light chain: a biomarker for genetic frontotemporal dementia

Meeter, L. H., Dopper, E. G., Jiskoot, L. C., Sanchez‐Valle, R., Graff, C., Benussi, L., Ghidoni, R., Pijnenburg, Y. A., Borroni, B., Galimberti, D., et al. (2016) · Annals of Clinical and Translational Neurology

Amyotrophic Lateral Sclerosis ResearchDementia and Cognitive Impairment Research

Cited by 263

Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity

Kuhle, J., Barro, C., Disanto, G., Mathias, A., Soneson, C., Bonnier, G., Yaldizli, Ö., Regeniter, A., Derfuss, T., Canales, M., et al. (2016) · Multiple Sclerosis Journal

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 257

Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD

Watanabe, M., Nakamura, Y., Michalak, Z., Isobe, N., Barro, C., Leppert, D., Matsushita, T., Hayashi, F., Yamasaki, R., Kuhle, J., et al. (2019) · Neurology

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 220

Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years

Cantó, E., Barro, C., Zhao, C., Caillier, S. J., Michalak, Z., Bove, R., Tomic, D., Santaniello, A., Häring, D. A., Hollenbach, J., et al. (2019) · JAMA Neurology

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 199

Serum neurofilament light chain levels are related to small vessel disease burden

Duering, M., Konieczny, M. J., Tiedt, S., Baykara, E., Tuladhar, A. M., Leijsen, E. V., Lyrer, P., Engelter, S. T., Gesierich, B., Achmüller, M., et al. (2018) · Journal of Stroke

Cerebrovascular and genetic disordersNeurological Disease Mechanisms and Treatments

Cited by 132

Neurofilament levels are associated with blood–brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis

Uher, T., McComb, M., Galkin, S., Srpova, B., Oechtering, J., Barro, C., Tyblova, M., Bergsland, N., Krasensky, J., Dwyer, M., et al. (2021) · Multiple Sclerosis Journal

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 86

Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum

Wilke, C., Preische, O., Deuschle, C., Roeben, B., Apel, A., Barro, C., Maia, L., Maetzler, W., Kuhle, J., & Synofzik, M. (2016) · Journal of Neurology, Neurosurgery & Psychiatry

Dementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research

Cited by 79